The Global Initiative to Speed the Delivery of Therapies for FSHD

Globe

These questions led to the formation of Project Mercury, a patient-led collaborative global initiative to ensure timely access to effective and affordable treatments for people affected by facioscapulohumeral muscular dystrophy (FSHD) everywhere.

About Project Mercury

About Project Mercury

Learn More
See how others are celebrating World FSHD Day

News & Updates

Spotlight on Country Working Groups – ABRAFEU, Brazil

Project Mercury works from one conviction: progress in FSHD has to be driven by the people who live with it. The Country Working Groups are where that conviction turns into practice. In each of our ten countries, patient organizations do not simply take part in the work. They lead it,

Read More »

This project is supported by the Innovative Health Initiative Joint Undertaking (IHI JU) under grant agreement No 101132943. The JU receives support from the European Union’s Horizon Europe research and innovation programme, COCIR, EFPIA, EuropaBio, MedTech Europe, Vaccines Europe (and the FSHD Society and TREAT-NMD Services Ltd as contributing beneficiaries participating in the project). The project will also receive funding from UK Research and Innovation (UKRI) under the UK government’s Horizon Europe funding guarantee [grant numbers 10105921, 10103989, and 10083579].

Funded by the European Union, the private members, and those contributing beneficiaries of the IHI JU. Views and opinions expressed are, however, those of the author(s) only and do not necessarily reflect those of the aforementioned parties. Neither of the aforementioned parties can be held responsible for them.

Translate »